Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-12-03 5:08 pm Purchase | 13D | F-STAR THERAPEUTICS INC FSTX | Cooperatieve AESCAP Venture I U.A. | 615,643 6.8% | 615,643 (New Position) | View |
| 2020-11-30 5:05 pm Purchase | 13G | F-STAR THERAPEUTICS INC FSTX | GSK plc GSK | 803,922 8.9% | 803,922 (New Position) | View |
| 2020-04-08 1:54 pm Sale | 13G | SPRING BK PHARMACEUTICALS INC SBPH | UBS Oncology Impact Fund L.P. | 603,070 3.5% | -833,839 (-58.03%) | View |
| 2020-02-14 3:25 pm Unchanged | 13G | SPRING BK PHARMACEUTICALS INC SBPH | BIOTECHNOLOGY VALUE FUND L P | 951,701 5.8% | 0 (Unchanged) | View |
| 2020-02-12 4:37 pm Sale | 13G | SPRING BK PHARMACEUTICALS INC SBPH | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0% | -1,000,000 (Position Closed) | View |
| 2020-01-06 4:36 pm Purchase | 13G | SPRING BK PHARMACEUTICALS INC SBPH | Ridgeback Capital Investments L.P. | 1,142,900 6.9% | 1,142,900 (New Position) | View |